In this group, 9 (21%) subjects were considered to have non-allergic asthma in the standard allergy work-up, including SPT and serum IgE.8 patients (19%) who still would not qualify for anti-IgE, anti-IL4, or anti-IL5 treatment. The gene discussed is IL5; the disease is allergic asthma.